The importance of optimal medical therapy in patients undergoing lower extremity bypass.
Curr Opin Cardiol
; 39(5): 451-456, 2024 Sep 01.
Article
em En
| MEDLINE
| ID: mdl-39110079
ABSTRACT
PURPOSE OF REVIEW The prevalence of peripheral artery disease is growing, with millions of people globally suffering its end-stage manifestation, chronic limb-threatening ischemia (CLTI). Revascularization procedures like lower extremity bypass play a vital role in limb salvage but optimal medical therapy is essential for maximizing the benefit of these procedures and reducing long-term risks of cardiovascular and limb-related events. RECENT FINDINGS:
Patients with PAD who undergo lower extremity bypass warrant a comprehensive approach to risk factor modification for both primary and secondary prevention of cardiovascular and limb-related complications. This includes appropriate use of high-intensity statins, smoking cessation, and management of hypertension and diabetes. Additionally, antiplatelet therapy is indicated for all patients with CLTI and additional treatment with low-dose anticoagulation may also be beneficial.SUMMARY:
Optimal medical therapy is essential for optimizing outcomes in patients with PAD undergoing lower extremity bypass.
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Extremidade Inferior
/
Doença Arterial Periférica
Limite:
Humans
Idioma:
En
Ano de publicação:
2024
Tipo de documento:
Article